













Sean Robert Gardner 
 












Submitted to the Graduate Faculty of 
The Dietrich School of Arts and Sciences in partial fulfillment 
of the requirements for the degree of 














Committee Membership Page 
UNIVERSITY OF PITTSBURGH 
 















Sean Robert Gardner 
 
 
It was defended on 
 
April 12, 2021 
 
and approved by 
 
Paul Floreancig, Professor, Department of Chemistry 
 
Craig S. Wilcox, Professor, Department of Chemistry 
 
































Towards The Total Synthesis of Tetrafibricin 
 
 
Sean Robert Gardner, MS 
 




This work describes the continuation of the total synthesis of the marine natural product 
Tetrafibricin in the Curran Group. Retrosynthetic analysis of the framework of tetrafibricin lends 
to a convergent synthesis using 6 fragments: C1-C8, C9-C13, C14-C20, C21-C30, C31-C34 and 
C35-C40. Following the last attempt that yielded approximately 1 mg of fully protected 
tetrafibricin, this attempt features scale up and reaction selection improvements in order to provide 
enough of the fragments in order to realize the successful coupling strategy demonstrated in 
previous work. The synthesis was unsuccessful in that a material bottleneck occurred for the C21-
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Platelet aggregation is an important function in the wound healing process as a response to 
damaged blood vessels. When the receptors GPIIb/IIIa on the surface of the platelet are bound by 
an agonist, these receptors highly increase affinity toward fibrinogen. This allows fibrinogen to 
act as a crosslinker between platelet cells and adhere to the location of the damaged arterial 
endothelium. This aggregation is the beginning of the normal clotting process as a response to 
arterial damage. Normal agonists of the fibrinogen receptor include collagen, thrombin, and ADP. 
1 
Due to age or buildup of plaques, arteries become more constricted and easily damaged, 
thereby reducing the ability of blood to circulate to the heart. In the event of inflammation of a 
blood vessel, the occurrence of platelet aggregation at a constricted site can cause blockage, 
leading to heart attack or stroke. Inhibition to the mechanism of normal platelet aggregation in the 
event of a coronary blockage provides a potential target to reverse those blockages. 
Recently, therapeutic fibrinogen antagonists have been reported,2 in which many are 
peptidomimetic compounds of the site of fibrinogen that binds to its receptor, which competitively 
occupy the receptor site and disrupt platelet aggregation. Issues with these peptide mimics are a 
low half-life in vivo, and a lower affinity for the fibrinogen receptor binding site than fibrinogen 
itself. 
Tetrafibricin is a fibrinogen receptor antagonist isolated from cultures of Streptomyces 
neyagawaensis NR0577.3 In biochemical assays, tetrafibricin is a strong competitive inhibitor (Ki 
 2 
= 9.9 nm) to biotinylated fibrinogen binding to immobilized glycoprotein receptor GPIIb/IIIa, as 
well as an inhibitor to fibrinogen binding to its receptors (IC50 = 46 nM). ADP-, collagen-, and 
thrombin-induced human platelet aggregation was also inhibited at IC50 values of 5.6, 11.0, and 
7.6 μM respectively.2 The ability of tetrafibricin to achieve strong in vitro inhibition of platelet 
aggregation makes it a good potential candidate for treatment of heart attack and stroke.4 
The structure of tetrafibricin was elucidated by the Kamiyama group in 1993, by carrying 
out various NMR, MS and other experiments.5 The molecular formula was determined as 
C41H67NO13 from HRFAB-MS, and a combination of 1H NMR, 13C NMR, 1H-1H COSY, HSQC 
and HMBC experiments were used to deduce partial structures. Additional NMR experiments on 
a solution of N-acetyldihydrotetrafibricin methyl ester were carried out to establish the complete 
connectivity of those partial structures, such that a two-dimensional structure of tetrafibricin was 
proposed (Figure 1.1). 





In 2003, the Kishi group reported the structural elucidation of the complete stereochemistry 
of tetrafibricin by comparison of its data with NMR databases of known compounds in achiral and 
chiral solvents (Figure 1.2).6 This approach came from a universal NMR database method that 
Kishi developed to assign the relative and absolute configuration of unknown compounds without 









The interesting biological properties of 1 and its unique, complex structure containing a 
primary amine, a conjugated tetraenoic acid, and multiple 1,3- and 1,5-diol groups render 
tetrafibricin an excellent target for synthetic study. The development of a convergent and efficient 
synthesis of tetrafibricin will aid in confirming its structure, supplying material for biological 
study, as well as potentially facilitate structure-activity relationship studies designed to probe its 
biological properties. 
The publications generated through the synthetic efforts put forth in the Curran group 
formed the basis for the strategy to prepare and couple the fragments of tetrafbricin8 To our 
knowledge at the time the work in this document was performed, there were four other research 
groups that had published their work towards the total synthesis of tetrafibricin. Cossy’s group 
synthesized the C1-C13, C15-C25, and C27-C40 fragments of tetrafibricin by a sequence of 
chemoselective cross-metathesis reactions and enantioselective allyltitanations of aldehydes.9 
Krische’s group reported the synthesis and coupling of the C31-C40 and C21-C30 fragments 
through a series of assymetric iridium catalyzed hydrogen transfer carbonyl allylation reactions 
and Grubb’s olefin metathesis reactions.10 
Roush’s group reported the synthesis of the C1-C19 fragment of tetrafibricin via a highly 
diastereoselective double allylboration developed in their laboratory.11 Later, they also reported 
improved double allylboration reagents to more efficiently allow access to (E)-1,5-syn-diols and 
demonstrated their application to the synthesis of the C23-C40 carbon framework of tetrafibricin.12 
 4 
Friestad’s group published an application of iterative Julia-Kocienski couplings of units with 
defined stereogenic centers to afford the repeating 1,5-polyol motif of C27-C40 fragment of 
tetrafibricin.13  
The Curran group’s synthetic work on tetrafbricin was stopped in 2013 following a paper 
outlining the total synthesis of N-acetyl dihydrotetrafibricin methyl ester was published.14 They 
described the instability of tetrafibricin while attempting to isolate it in its pure form following 
global deprotection. They chose to proceed to instead complete the synthesis of a closely related 
derivative that Kishi had used in the spectroscopic determination tetrafibricin’s structure, as this 
derivative was determined to stable enough to be characterized spectroscopically and matched to 
previously obtained data.6 Characterization of the derivatized natural product confirmed Kishi’s 
assignments.  
In the period of time following the conclusion of this work, there have been further 
synthetic studies on construction of tetrafibricin’s framework and stereochemical makeup. 
Krische’s group in 2014 expanded the use of their iridium catalyzed assymetric carbonyl  allylation 
strategy and included ruthenium catalyzed syn-crotylation reactions to prepare the C9-C20 
fragment.15 Friestad’s group in 2017 presented and expanded version16 of their iterative Julia-
Kocienski olefination strategy for the C15-C25 fragment17 and in 2018 released a pair of 
publications outlining the synthesis of the required subunits and their application to the syntheses 
of C15-C25 and C26-C40 fragments studies on conditions required to couple the fragments in an 
enantioselective manner. 18 
 5 
1.2 Retrosynthetic Analysis and Previous Work in the Curran Group 
The retrosynthetic analysis of tetrafibricin 1 (Figure 1.3) can be envisioned such that a 
series of Julia-Kocienski olefination19 reactions would provide strategic disconnects to couple 
fragments 2, 3, 4, 5 together to form bonds C20-C21, C30-31 and C34-C35 (disconnections A).  
An umpolung approach for forming the acyl C13-C14 (disconnection B) bond can be achieved 
with fragments 5 and 6. The C8-C9 bond can be formed through a Horner-Wadsworth-Emmons 
(HWE) olefination to couple fragments 6 and 7 (disconnection C). 












Dr. Venugopal Gudipati successfully synthesized all fragments 2-7.8 The strategy was 
planned such that the full carbon framework of tetrafibricin would be coupled together in two large 
fragments with the key connection point being the C20-C21 bond. The C21-C40 fragment would 
be assembled from 2, 3 and 4 (Figure 1.2) and the C1-C20 fragment would be assembled from 5, 
 6 
6, and 7. 
Fragments 2 and 3 were coupled first via a Julia-Kocienski olefination to give an alkene in 
a 9:1 E/Z isomeric mixture in 95% yield.20 The conversion of sulfide to sulfone 8 with catalytic 
Mo7O24(NH4)6•H2O treated with H2O221 occurred in 92% yield.  
Another Julia-Kocienski olefination reaction between the sulfone 8 and aldehyde 9, a 
precursor to 4, provided the alkene 10 as a single (E)-isomer about the C30-C31 alkene in 94% 
yield. Removal of the PMB protecting group by using DDQ and pH 7 buffer in dichloromethane22 
gave the primary alcohol 11 in 88% yield. Installation of the thiotetrazole via the Mitsunobu 
reaction,23 employing commercially available 1-phenyl-1H-tetrazole-5-thiol (PTSH), followed by 
oxidation of the derived sulfide gave the sulfone 12, the C21-C40 fragment, in 65% yield over two 
steps. 














The synthesis of the C1-C20 fragment 12 was constructed by coupling the smaller 
fragments 5, 6 and 7 (Figure 1.5). Deprotonation of dithiane 6 with t-BuLi followed by addition 
of iodide 5 provided the target alkylated dithiane 13 in 54% yield. Hydroboration and oxidation of 
alkene provided the primary alcohol, which was oxidized to aldehyde 14 with SO3•pyr and 
DMSO24 in 58% yield over two steps. A Horner-Wadsworth-Emmons olefination20 was then 
carried out by deprotonation of phosphonate 7 with LiHMDS followed by the addition of 14 to 
afford 15 in 57% yield. The primary TBS-ether was cleaved with HF•pyr to give the primary 
alcohol in 45% yield. This was oxidized with SO3•pyr and DMSO to give the C1-C20 fragment 
16 in 85% yield. 
 













With the two large fragments in hand, coupling by a Julia-Kocienski olefination12 was 
attempted (Figure 1.6). Sulfone 12 was deprotonated with KHMDS in THF at –78 ˚C, followed 
by addition of aldehyde 16. Unfortunately, the coupled product 17 was not isolated. 
 






A revision of approach was carried out by Dr. Kai Zhang.25 The six fragments were re-
synthesized, and attempts were made to couple the fragments in a different order. The syntheses 
of the C21-C40 framework as sulfone 16 and preparation of C9-20 framework 13 were repeated 
(Figure 1.7).  Alkene 13 was hydroborated/oxidized to give the primary alcohol in 68% yield, 
which was the protected as the benzoyl ester 18 in 88% yield. Selective desilylation of the primary 
alcohol using HF•pyr26 resulted in the primary alcohol in 42% yield, followed by Swern 
oxidation27 to give aldehyde 19 in 60% yield. With the coupling partners prepared, Julia-Kocienski 
olefination was performed by deprotonating sulfone 12 with KHMDS in dry dimethoxyethane 














Given the two unsuccessful attempts at olefination at C20-C21, a strategy was devised to 
use the C21-C30 fragment 4 alone to couple with aldehyde 19, while the C31-C40 framework 
from fragments 2 and 3 would be assembled separately, and then attached afterward (Figure 1.8). 





















Further modification of 20 was needed to allow coupling of the C31-C40 component. The 
primary TBS group needed to be removed in the presence of eight secondary TBS groups. Then, 
the resulting primary alcohol needed to be oxidized to make the aldehyde for the next Julia-
Kocienski coupling (Figure 1.9). Silyl ether 20 was treated with HF•pyr in pyridine and THF to 
achieve a meager yield of 21. To improve this step, the synthesis of 4 was revisited and it was 
determined that the substitution of a more labile triethylsilyl (TES) group on the primary alcohol 
to selectively cleaved in the presence of TBS groups. When the primary alcohol was protected 






















The C31-C40 fragment 8 was successfully coupled to 22 in 45% yield to give the C9-C40 
fragment 23 (Figure 1.10). Saponification of the benzoyl ester with KOH and oxidation of the 
resulting alcohol with the Dess-Martin reagent28 gave 1.5 mg of crude aldehyde 24. The final 
Horner-Wadsworth-Emmons olefination for the final coupling of 7 to 24 yielded approximately 1 
mg of fully protected tetrafibricin 25. This was enough material for 1H NMR characterization yet 
was not enough to carry through a global deprotection, as this would result in the loss of more than 
half of the molecular weight of the molecule. 
A successful route to obtaining the carbon framework of tetrafibricin 1 was achieved. A 
goal of synthesizing 0.5 mmol of 1 has been set in order to undertake spectroscopic studies to 
compare to the natural product, as well as provide material for preliminary biological study. 
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2.0 Synthesis of Tetrafibricin’s Fragments 
In order to successfully complete the total synthesis of tetrafibricin 1, larger quantities of 
each of the fragments are needed. Deficiencies in the yields of key reactions and coupling strategies 
limited material throughput. Though the synthetic routes to each of the fragments are already in 
place, improvements need to be made in order to provide enough material to complete the 
synthesis. 
2.1 Progress toward C21-C30 Fragment Synthesis 
Synthesis of the C21-C30 fragment 4 of tetrafibricin was performed by Dr. Zhang up to 
compound 38 in Figure 2.4.25 The key step in this reaction sequence is the coupling between 
dithiane 26 and epoxide 27, and the selective deprotection of the primary alcohol in the final steps 
of the fragment synthesis (Figure 2.1).   




The “left hand side” 26 of the C21-C30 fragment was synthesized starting with 
commercially available (4S)-(+)-4-(2-hydroxyethyl)-2,2-dimethyl-1,3-dioxolane (Figure 2.2). 
Swern oxidation27 of the primary alcohol, followed by distillation under reduced pressure gave 
aldehyde 28 in 71% yield. Generation of the ylide of methyl triphenylphosphonium bromide with 
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n-butyllithium29, followed by addition of 28 and purification by Kuhgelrohr distillation gave 
alkene 29 in 83% yield. The crude aldehyde was dissolved in DCM, and was treated with 3-
chloroperoxybenzoic acid (m-CPBA) to afford oxirane 30 as a 58:42 mixture of syn/anti 
diastereomers. The crude epoxide was dissolved in AcOH and THF, and was treated with (S,S)-
Jacobsen reagent30 and water to affect a hydrolytic kinetic resolution. Enantiomerically pure (S,S)-
30 was obtained in 38% yield following Kuhgelrohr distillation under reduced pressure.  
 
Figure 2.2 - Synthesis of the “Left Hand Side” of the C21-C30 Fragment 
 
 
1,3-Dithiane was lithiated using t-BuLi at –78 ̊ C in THF and HMPA, followed by addition 
of epoxide (S,S)-30, which underwent nucleophilic ring opening to give dithiane 31 in 87% yield 
after purification by flash chromatography. Acetonide cleavage was effected by treatment of 31 
with catalytic acetyl chloride in MeOH to give triol 32. Without further purification, 32 was treated 
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with excess TBSOTf and 2,6-lutidine to afford tris-silyl ether 26 in 82% yield after flash 
chromatography. 
The “right hand side” 27 of the C21-C30 fragment was synthesized following procedures 
outlined in the thesis of Dr. Zhang.25 Starting from commercially available (4R)-(–)-4-(2-
hydroxyethyl)-2,2-dimethyl-1,3-dioxolane, deprotonation of the primary alcohol by NaH in DMF, 
followed by alkylation with p-methoxylbenzyl (PMB) chloride gave PMB ether 33 in 87% yield. 
Acetonide cleavage with catalytic acetyl chloride in methanol gave diol 34 in 88% yield. Next, 
Mitsunobu conditions23 were used to perform the final ring closing reaction. Diol 34 was dissolved 
in toluene with triphenylphosphine and diisopropylazodicarboxamide, and the mixture was heated 
to reflux temperature overnight to afford epoxide 27 in 87% yield. 
 






With compounds 26 and 27 in hand, coupling and further modification of the C21-C30 
fragment was advanced (Scheme 2.4). Lithiation of 26 by t-BuLi at –78 ˚C in THF/HMPA 
followed by slow addition of epoxide 27 gave the coupling product 35 in 70% yield. Dithiane 
hydrolysis was achieved 83% yield after purification by flash chromatography by treating 35 with 
Hg(ClO4)2•3H2O and 2,6-lutidine in 4:1 THF/H2O at 0 ˚C to give ketone 36.31 Directed 1,3-anti 
reduction was performed by addition of an acetic acid solution of tetramethylammonium 
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triacetoxyborohydride32 to solution of 36 in propionitrile at –25 ˚C. Crude diol 37 was silylated 
with TBSOTf and 2,6-lutidine to give pentakis-silyl ether 38 in 70% yield after flash 
chromatography.  
 











Attempts by Dr. Zhang to selectively cleave the primary TBS group from the primary 
alcohol of 38 by using HF•pyr in a pyridine/THF mixture resulted in a 33% yield of alcohol 39 
(Figure 2.5). Low yield for this reaction became a limiting factor to procuring the necessary 
amount of material needed to successfully complete the synthesis. Thus, more selective conditions 
were sought after. 
Further reactions were attempted to achieve selective desilylation of the primary alcohol 
of 38.33 Treating 38 with 20 mol% camphorsulfonic acid in dichloromethane did not show selective 
cleavage of the primary silyl group when monitoring by TLC. A reaction with 0.1 equiv of acetyl 
chloride in methanol at –20 ˚C resulted in multiple UV-active bands that observed by TLC. A 
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reaction using a 1:1 TBAF/AcOH reagent system as a source of buffered fluoride ion was 
performed. These conditions were the most successful alternative to HF•pyr, however this only 
resulted in 18% yield of 39. 
During subsequent attempts to repeat and improve upon this reaction, complex mixtures of 
39 were observed. Separation of the impurities could not be achieved through automated flash 
chromatography.  It has not been determined whether the impurities were present in the sources of 
38, or were the result of a lack of selectivity of the deprotection conditions. 
 





With the small amount of pure 39 obtained from desilylation, the completion of the 
synthesis of C21-C30 fragment 4 was attempted (Figure 2.6). Reprotection of the primary alcohol 
39 using TESOTf resulted in an inseparable mixture of products. This reagent system is known to 
be incompatible with the PMB protective group due to the strong Lewis acidity of the silyl triflate 
present.34 Treatment of alcohol 39 with TESCl, imidazole, and DMAP in DMF afforded the 
desired product 40 in 75% yield. Deprotection of the PMB ether of 40 was achieved in 84% yield 
in a biphasic DCM/aqueous pH 7 buffer solvent mixture by treatement with DDQ to give alcohol 
41. Synthesis of sulfide 42 was attempted through a Mitsunobu reaction between alcohol 41 and 
PTSH. The desired product was not detected in the crude mixture 1H NMR spectroscopy, so the 














The difficulty in achieving selective removal of the primary silyl protecting group of 38 
presents a barrier to producing enough of fragment 4 to ultimately complete the synthesis of 
tetrafibricin 1. With compound 26 available, differentiation of the protecting groups installed on 
the primary and secondary alcohols can be done at an earlier stage. This can be achieved by 
deprotecting all three of the TBS ethers, selectively protecting the primary alcohol, and then 
protecting the remaining two secondary alcohols. 
2.2 C14-C20 Fragment Synthesis 
The synthesis of the C14-C20 fragment 5 was accomplished by using procedures in Dr. 
Zhang’s thesis.25 The assembly of the carbon framework of 5 began with commercially available 
(4S)-(+)-4-(2-hydroxyethyl)-2,2-dimethyl-1,3-dioxolane (Figure 2.7). Oxidation under Swern 
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conditions, followed by distillation of the crude product under reduced pressure gave aldehyde 43 
in 85% yield. Treatment of 43 with 1,3-propanedithiol and BF3•OEt2 for 1 h resulted in 
simultaneous acetonide cleavage and dithiane formation to give 44 in 76% yield after flash 
chromatography. Protection of the diol with TBSOTf and 2,6-lutidine resulted in dithiane 45 in 
93% yield. Preparation of the coupling partner to 45 was achieved by deprotonation of (S)-(–)-
glycidol with sodium hydride in THF, followed by addition of PMBCl and 10 mol % Bu4NI to 
give 46 in 64% yield.  Alkylation of 45 proceeded by treatment with t-BuLi and HMPA at –78 ˚C, 
followed by slow addition of epoxide 46 to give 47 in 58% yield after flash chromatography. 
 









With the carbon framework of 5 in place, further work was necessary to set the final 
stereogenic center and manipulate protecting groups (Figure 2.8). Hydrolysis of dithiane 47 with 
Hg(ClO4)2•3H2O in a 4:1 THF/H2O solution at 0 ˚C gave ketone 48 in 87% yield following flash 
chromatography. Caution was taken to maintain the temperature of the mixture below 10 ̊ C during 
the portion-wise addition of the mercury salt to the reaction, especially at the multi-gram scale. 
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These conditions have demonstrated to be explosive in nature if the reaction is unable to dissipate 
heat efficiently.31 The reaction was carried out safely by using a sufficient volume of solvent to 
transfer heat, and closely monitoring the reaction temperature and operation of the magnetic 
stirring apparatus. 
1,3-Syn-reduction of 48 was first attempted following a procedure described in the theses 
of Drs. Zhang and Gudipati8c, 25. A solution of Et2BOMe in THF35 was added to a 4:1 THF/MeOH 
solution of 48 at –78 ˚C, followed by NaBH4 after 30 min. After 3 h the reaction was quenched 
with H2O, and subsequent extraction and flash chromatography gave syn-diol 49 in 88% yield. In 
contrast to these high yields, Dr. Mandel reported inconsistent yields up to 56% of 49 in more 
recent attempts.36 
When this procedure was repeated, purification of the crude product by flash 
chromatography gave not one product, but two. The second-eluting, minor product was determined 
to be the expected syn-diol 49 in 30% yield. This exhibited 1H NMR and 13C NMR resonances 
identical to those previously reported. The first-eluting major product had NMR resonances similar 
to 49, however, some of the chemical shifts were different. There were also new resonances 
corresponding to an ethyl group (∂ 0.67, q, 2H, and ∂ 0.88, t, 3H). Based on this, the major product 
was proposed to be cyclic borinate ester 50. A 11B NMR spectrum was obtained, and a broad 
singlet at ∂ +31.0 was observed. This is consistent with 11B NMR shifts to similar cyclic borinate 
esters.37 Treatment of this major product with H2O2 and NaOH gave conversion to the desired syn-
diol 49 further supporting 50 as the proposed structure.  
Next, the reduction was repeated, and in lieu of quenching with water, the crude product 
was treated with aqueous H2O2 and NaOH for 1 h.38 This resulted in isolation of syn-diol 49 in 
94% yield after flash chromatography, with no trace of the previously observed borinate.  
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Silylation of 50 with TBSOTf and 2,6-lutidine resulted in 51 in 96% yield. Subsequent 
cleavage of PMB ether 51 with DDQ in DCM/aqueous pH 7 buffer resulted in primary alcohol 52 
in 99% yield after flash chromatography.  
 
Figure 2.8 - Protecting Group Manipulation of Fragment 5 Intermediates 
 
 
Iodination of primary alcohol 52 (Figure 2.9) was initially achieved by using PPh3, I2, and 
imidazole39 in DCM at 0 ˚C in 36% yield (entry 1, Table 2.2.1), in contrast to 96% yield reported 
by Dr. Zhang.25 Increasing the reaction time and gradually raising the temperature to 23 ˚C (entry 
2), or increasing the amount of the reagents used (entry 3) only afforded a minor increase in 
isolated yield with complex product mixtures. Fuwa and coworkers40 reported that using benzene 
as a solvent achieved excellent conversion in a related system. Using this information, a series of 
1H NMR experiments were performed in order to determine the effects of the solvent used on the 
yield of the reaction.  
A reaction performed in CD2Cl2 resulted in a complex mixture of products over 30 min 
(entry 4).  A reaction in benzene-d6 was monitored by 1H NMR, and showed complete conversion 
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of 52 to the desired iodide 5 after 30 min (entry 5). A reaction was performed with toluene to 
explore an alternative solvent to benzene, however the yield of the reaction was only 25% (entry 
6). These results showed that using benzene gave the best yield for this reaction. Under these 
optimized conditions, a scale-up synthesis of 5 was achieved in 99% yield after flash 
chromatography (entry 7) at a 15 g scale. Overall, the C14-C20 fragment 5 was synthesized in an 
overall yield of 26% over 10 steps. 
 





Table 2.1 - Optimization of Iodination Conditions 
a Isolated yield b Yield determined by NMR spectroscopy c Results reported by Dr. Zhang 
Entry PPh3 (eq) I2 (equiv) imid. (equiv) Solvent (conc) Temp Time Yield 5 
1 1.4 1.1 1.5 DCM (0.15 M) ˚C 0.5 h 36%a (96%)c 
2 1.4 1.1 1.5 DCM (0.15 M) 23˚C 7 h 41%a 
3 2.5 2.0 3.0 DCM (0.15 M) 0 ˚C 3 h 51%a 
4 1.8 1.9 2.0 CD2Cl2(0.08 M) 23 ˚C 0.5 h Complexb 
5 1.8 1.9 2.0 C6D6 (0.08 M) 23 ˚C 0.5 h 100%.b 
6 1.8 1.9 2.0 PhMe (0.08 M) 23 ˚C 0.5 h 25%b 
7 1.8 1.9 2.0 PhH (0.08 M) 23 ˚C 1 h 99%a 
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2.3 C9-C13 Fragment Synthesis 
The C9-C13 fragment 6 was synthesized by using procedures outlined by Dr. Zhang25 
(Figure 2.3.1). Chiral auxilliary (R)-4-benzyl-2-oxazolidinone was deprotonated with n-BuLi at –
78 ˚C, then the resulting anion was acylated with propionyl chloride resulting in 53 in 97% yield. 
An Evans aldol reaction41 was performed through enolization of 53 with dibutylboron 
trifluoromethanesulfonate and triethylamine at 0 ˚C. Cooling to –78 ˚C and addition of freshly 
distilled acrolein gave 54 in 15% yield. Protection of the alcohol of 54 with TBSOTf gave 55 in 
97% yield after flash chromatography.  
 







The remainder of the synthesis of fragment 6 was completed by Dr. Julien Monot. 
Reductive cleavage of the Evans auxiliary with LiBH4 in THF32 gave alcohol 56 in 87% yield. 
Alcohol 56 was oxidized under Swern conditions to give crude aldehyde 57, which was treated 
with MgBr2•OEt2 and 1,3-propane dithiol (Figure 2.3.2). After flash chromatography, it was 
determined by Dr. Monot that epimerization at methyl-bearing carbon had occurred during this 
sequence, giving syn-6 mixed with anti-6 in a ~7:3 ratio. This could have occurred due to reversible 
enolization by the triethylamine used in the Swern oxidation. The mixture of syn-6 and anti-6 was 
 24 
treated with TBAF, and the diastereomers of the resulting alcohol were separated 
chromatographically to give (S,R)-58 and (S,S)-58. The pure diastereomers were separately treated 
with TBSOTf and 2,6-lutidine by to give fragment 6 from (S,R)-58 in 93% yield by Dr. Monot, 
and 25 from (S,S)-23 in 98% yield by the author. 
A 2,2,6,6-tetramethylpiperidinyloxy radical (TEMPO) oxidant / bis-acetoxyiodobenzene 
(BAIB) co-oxidant system42 was evaluated to try to eliminate the epimerization. TEMPO/BAIB 
oxidation of alcohol 56 resulted in aldehyde 57 in 99% yield as a single diastereomer. Subsequent 
treatment of the crude aldehyde with MgBr2•OEt2 and 1,3-propane dithiol gave dithiane 6 in 83% 
yield without epimerization. Overall, C9-C14 fragment 6 was synthesized in 50% yield over six 
steps. 










2.4 Synthesis of Fragment 7 (C1-C8) 
The C1-C8 fragment 7 is the last fragment to be coupled to form the full carbon framework 
of tetrafibricin. The ethyl ester of 7 was synthesized by the Roush group as the C1-C8 synthon in 
their synthesis of the C1-C19 fragment of tetrafibricin11. Due to the extended conjugation of 7, 
care was taken to shield polyene intermediates from light during reactions and storage.  
Synthesis of 7 began with diesterification of commercially available (E,E)-muconic acid 
to dimethyl ester 60, which was achieved with acetyl chloride in methanol (Figure 2.12). 
Subsequent reduction of the crude material with DIBAL-H gave allylic diol 61 in 97% yield over 
two steps without purification. Monosilylated diol 62 was obtained from a statistical mixture in 
46% yield, followed by allylic oxidation to aldehyde 63 with activated MnO2 in 98% yield after 
flash chromatography. Horner-Wadsworth-Emmons olefination between 63 and tert-butyl 
diethylphosphonoacetate gave 64 as a single (E)-isomer in 77% yield. Desilylation with TBAF 
provided allylic alcohol 65 in 96% yield. 
 
Figure 2.12 - Preparation of the C1-C8 Fragment Precursor 65 
 
Dr. Zhang’s route25 to the methyl ester analog of fragment 7 involved a traditional 
halogenation/Arbuzov reaction sequence.43 The same reaction sequence to afford 7 from 65 proved 
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to be problematic. Treatment of allylic alcohol 65 with thionyl bromide gave bromide 66 in only 
46% yield, likely due to the acid sensitivity of tert-butyl esters. Chromatographic purification and 
storage of 66 also proved problematic due to its relative instability to ambient laboratory conditions 
and light. Bromide 66 and triethylphosphite were heated to reflux in toluene in the dark to give 
phosphonate 7 in 56% yield. However, this reaction was not reproducible, which was attributed to 
thermal decomposition under these conditions. 
Wiemer and coworkers44 described a zinc iodide mediated Arbuzov-type reaction to 
convert allylic alcohols directly to their corresponding phosphonates at reflux in toluene.  The 
reaction between zinc iodide, triethylphosphite and alcohol 65 at 55 ˚C gave a 31% yield of the 
target product 7 (Table 2.4.1, Entry 1). Elevating the temperature to 80 ˚C resulted in 
decomposition being observed after 1 h (Entry 2). A reaction in THF at 55 ˚C showed no 
conversion to 7 by TLC analysis. Running the reaction as a neat mixture at 55 ˚C showed an 
increase in yield to 54% (Entry 4), however running the reaction longer than 2.5 h showed no 
appreciable benefit. 
 











Table 2.2 - Optimization of ZnI2 Mediated Arbuzov-Type Reaction 
 
 
Replacement of the traditional halogenation/Arbuzov sequence with the optimized zinc 
mediated reaction conditions shortened the synthesis of 7 to seven steps from eight and led to 
increased conversion of allylic alcohol 65 to fragment 7 in 54% yield in one step rather than the 
previously achieved 25% yield over two steps. The C1-C8 fragment 7 was synthesized in an overall 
yield of 17% over seven synthetic steps.  
2.5 C9-C13 and C14-20 Fragment Coupling and Modification 
Once the synthesis of the individual fragments was complete, the carbon framework of 
tetrafibricin could be constructed through coupling the fragments. The first fragment coupling 
reaction was to join the C9-C13 fragment 6 and the C14-C20 fragment 5 through a Corey-Seebach 
reaction to give 13 (Scheme 2.14).31 Dithiane 6 was lithiated in the presence of HMPA with t-BuLi 
at –78 ˚C, followed by addition of iodide 5. As reported by Dr. Zhang, the reaction between 5 and 
6 in a 1:1 molar ratio in the presence of 1.1 equiv t-BuLi resulted in coupled product 13 in 54% 
yield (Table 3, entry 1). However, purification of the product by flash chromatography was 
difficult because the starting material and product co-eluted. Addition of 1.3 equiv of 5 to 1.0 equiv 
Entry P(OEt)3 (eq) ZnI2 (eq) Solvent Temp Time Yield 
1 3.0 1.5 PhMe (0.1M) 5 ˚C 3 h 31 % 
2 3.0 1.5 PhMe (0.1M) 0 ˚C 1 h decomp 
3 3.0 1.5 THF (0.1M) 5 ˚C 6 h No conv 
4 6.0 3.0 neat 5 ˚C 2.5 h 54 % 
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of lithiated 6, as suggested by a procedure performed by Hanessian and coworkers,45 gave coupled 
product 13 in 75% yield (entry 2). Even with the large improvement in yield, chromatography was 
still difficult because both 5 and 6 still remained in the crude product mixture. Addition of 1.0 
equiv of 5 to 1.1 equiv of lithiated 6 achieved nearly complete coupling to give 13 in 96% yield 
(entry 3). 




Table 2.3 - Conditions for the Coupling of Fragments 5 and 6 
a Results reported by Dr. Zhang 
  
Following coupling, 13 was advanced to allow for further fragment coupling later in the 
synthesis (Figure 2.11). The terminal alkene of 13 was hydroborated with 9-BBN.46 Oxidative 
workup with aqueous H2O2 and NaOH gave alcohol 67 in inconsistent yields. In many cases the 
product was contaminated with impurities that were difficult to separate by column 
chromatography. We considered that the dithiane of the substrate could react with the H2O2 used 
with the workup, so a milder oxidant was sought. Treatment of the in situ generated trialkylborane 
of 13 with NaBO3 4H2O gave 67 in 88% yield.47 Protection of the primary alcohol as benzoate 
ester 68 was achieved with benzoyl chloride and triethylamine in 94% yield. 
Entry 5 (equiv) 6 (equiv) t-BuLi (equiv) Time Yield 13 
1 1.0 1.0 1.1 2 h 54%a 
2 1.3 1.0 1.2 2.5 h 75% 
3 1.0 1.1 1.2 2 h 96 % 
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The next key step was to selectively deprotect the TBS group of the primary alcohol of 68 
in the presence of the remaining four secondary silyl ethers (Figure 2.12). Dr. Zhang removed of 
the primary silyl group of 68 using HF•pyr/pyr in THF to afford 69 in 39% yield.  
This reaction was repeated, and after 5 h, a 30% yield of 69 was isolated, 20% of the 
starting material 68 was recovered, and the remainder of the substrate was presumed to have been 
desilylated at more than one site to give 70 as a mixture of polyols. Improved conditions were 
sought after in order to increase selectivity of primary silyl ether removal to give 69 in higher 
yield, and also to make recovery of 70 more efficient in order to resilylate the deprotected alcohols 
to regenerate 68. Recovered 68 would be subjected to the conditions again and recycled.33 
Acidic conditions were first attempted to remove of primary silyl group, because 1,4- and 
1,5-silyl transfer readily occurs under basic conditions.34 It had been reported that the treatment of 
61 with “acidic chloroform,” prepared by treatment of chloroform with concentrated aqueous HCl 
successfully removed a primary silyl group in a similar 1,2-silyloxy system.34 Tetrakis-silyl ether 
61 was dissolved in acidic chloroform, and the reaction was monitored by TLC. Several UV-active 
bands were present in close proximity to the Rf of the desired product 69 when monitored by TLC, 
suggesting a lack of selectivity. After 4 h, an impure sample of primary alcohol 69 was isolated in 
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15% yield, along with 60% of 68, with the remaining material isolated as a mixture of polyols 
(70). Treatment of 68 with AcOH in THF for 3 days resulted in the isolation of starting material 
in near quantitative yield.  
Lewis acidic conditions were also unsuccessful. Treatment of 68 with 1 equiv of 
Cu(NO3)2•H2O resulted in non-selective desilylation as observed by TLC. Treatment of 68 with 5 
equiv BF3•OEt2 also resulted in non-selective desilylation by TLC. Next, use of a basic fluoride 
source was attempted through the treatment of 68 with TBAF in THF. After two days there was 
no change to the reaction when monitored by TLC.  
Next, buffered fluoride sources other than HF•pyr were used to affect selective desilylation. 
It was our hope that less reactive conditions would decrease the deprotection reaction rate of the 
secondary alcohols while maintaining reactivity with the primary silyl ether. Addition of NH4F to 
a solution of 68 in MeOH showed no appreciable change to the mixture by TLC after two days. A 
solution of TBAF in THF buffered with AcOH was used to treat 68 to afford primary desilylation. 
After 6 h, the desired product 69 was isolated in 26% with recovered 68 in 57% yield, while over-
reacted substrate 70 was recovered in approximately 17% yield. The polyol mixture 70 was treated 
with TBSOTf and 2,6-lutidine to afford 68 in 79% yield.  
Though these conditions have a lower yield of 69 than using HF•pyr, the total recovered 
mass balance is higher. Treatment of a sample of 68 in three iterations of deprotection and recovery 
resulted in an overall yield of 55% of 69, recovery of 68 in 8% yield, and the remaining polyol 













2.6 Model Coupling of C1-8 Fragment and Test Deprotection 
After the final fragment 7 will be coupled to complete the full carbon framework of 
tetrafibricin, the deprotection strategy will be to first hydrolyze the dithiane at C13 to a ketone, 
followed by global deprotection of all of the silyl groups and the tert-butyl ester. In order to test 
the viability of dithiane hydrolysis in the presence of the tetraene moiety indroduced by coupling 
fragment 7, a model system was constructed and subjected to conditions to afford this 
transformation. 
Lithiation of anti-6 with t-BuLi in the presence of HMPA at –78 ̊ C, followed by alkylation 
with 1,2-epoxydodecane gave 71 in 72% yield after flash chromatography (Figure 2.13). The 
resulting diastereomeric mixture of alcohols was silylated with TBSOTf  at –78 ˚C to give 72 in 
75% yield.  The alkene of 72 was hydroborated with 9-BBN, then treated with H2O2 and NaOH to 
afford primary alcohol 73 in 61% yield. 
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Oxidation of 73 with TEMPO and BAIB42  afforded an impure sample of aldehyde 74 in 
27% yield. However, the by-products were difficult to separate from the product. In contrast, 
oxidation with Dess-Martin periodinane afforded aldehyde 75 in 70% yield in good purity after 
flash chromatography. 







Next, 74 and 7 were coupled through a Horner-Wadsworth-Emmons olefination reaction 
(Figure 2.14).20 Treatment of 7 with LiHMDS at –78 ˚C, followed by addition of aldehyde 74 to 
give tetraene 75 in 90% yield as a single (E)-isomer, evident from the coupling constants of the 
new alkene resonances (6.37 ppm, dd, J = 14.6 Hz, 11.7 Hz; 6.13 ppm, dd, J = 15.0, 10.7 Hz). 
Dithiane 75 was then treated with Hg(ClO4)2•3H2O and 2,6-lutidine in a 4:1 mixture of THF/H2O 
at 0 ˚C for 1 h to afford ketone 76 in 45% yield after flash chromatography. Analysis of the 1H 
NMR spectra of 76 shows the dithiane resonances are not present as compared to 75, and the eight 
alkene resonances remain present (refer to the spectra in the experimental section). Resonances 
observed in the 13C NMR show the presence of a ketone for each of the diastereomers (212.3 and 
211.9 ppm). This experiment shows the tetraene is stable to the conditions required for final 













2.7 Attempts to Complete the Synthesis of the C21-C30 Fragment 
The resynthesis of the C21-C30 fragment for the purpose of completing this work was 
started by Dr. Zhang, however the resulting material was below the required amount to complete 
the synthesis at or above the target quantity. The first priority at this stage in the synthesis was to 
perform the final steps toward synthesis of the C21-C30 fragment 4 in preparation for the Julia-
Kocienski coupling reaction to the C9-C20 framework. A decision was made to proceed using the 
available late stage intermediates available. The most readily available source of an intermediate 
leading to 4 was the fully TBS protected framework 38 synthesized by Dr. Zhang. Differentiation 
of the protecting group on the primary alcohol to a more labile silyl group (in this case, a TES 
group) was the primary objective in order to facilitate later stage deprotection for coupling when 
material is more limited (Figure 2.15). Using the conditions that were determined to be most 
successful for the selective desilylation of the primary alcohol leading to C9-C20 fragment 69, 
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compound 38 was treated with TBAF/AcOH in THF. These conditions led to a similar result in 
which the desired product 39 was obtained in 18% yield, as well as recovered multiple desilylated 
products (23%) and recovered starting material 38 (46%). This reaction fared slightly better on a 
smaller scale with isolation of 39 (26%), recovery of starting material 38 (25%) and multiple 
desilylated products (37%).  
 
Figure 2.19 - Selective Deprotection of 38 
 
 
With 39 in hand, the primary alcohol was protected with the more labile TES group in 
order to enhance selective deprotection of the primary alcohol after coupling (Figure 2.16).  
Initially, this transformation was attempted by treatment of 39 with TESOTf and 2,6-lutidine. This 
reaction resulted in a complex mixture by TLC. This is likely due to the Lewis acidity of TESOTf, 
which has been described as being reactive toward PMB ethers. With this result, milder conditions 
were employed by treatment of 39 with TESCl and imidazole. This change in reagent system was 
successful, resulting in the isolation of the desired product 40 in 75% yield. The next step planned 
in the sequence was orthogonal deprotection of the PMB- protected primary alcohol. Treating 40 







Figure 2.20 - Modification of 39 
 
 
With 41 (approx. 125 mg) in hand, the final modifications to prepare the coupling partner 
for the Julia-Kocienski olefination reaction were underway. Primary alcohol 41 was subjected to 
Mitsunobu conditions using PTSH as a nucleophile in order to arrive at sulfide 42 (Scheme 2.7.3). 
After two attempts with limited material, analysis of the crude 1H NMR determined that the 
reaction mixture did not contain the desired product. At this point, it was evident that greater 
quantities of the C21-C30 fragment were to be necessary in order to move the synthesis forward. 
 
Figure 2.21 - Preparation of the Julia-Kocienski Coupling Partner 42 
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2.8 Attempts to Produce Additional Quantities of Fragment C21-C30 
The synthetic pathway outlined by Dr. Zhang25 was decided to be the best course of action 
to most rapidly access the material needed to continue the coupling of the final fragments that were 
already in hand. Dithiane 27 was available in multi-gram quantities to move forward with the 
resynthesis, such that furthering the material towards the full C21-C30 required epoxide 27 
(Scheme 2.1.4). The first step was to protect commercially available (4R)-(–)-4-(2-hydroxyethyl)-
2,2-dimethyl-1,3-dioxolane by synthesis of its p-methoxybenzyl ether 84 by treatment with 
PMBCl (Figure 2.18). The reaction was performed twice on a 5 g scale, to result in 15.45 g of 33 
to continue with the required transformations. The following step was deprotection of the 
acetonide of 33 under acidic conditions. Initially, 10 mol% p-toluenesulfonic acid monohydrate 
was used, however this led to less than ideal yield with lowered material throughput. Conditions 
using 20 mol% acetyl chloride to generate hydrogen chloride in situ resulted in improved yields 
of 34. The resulting diol 34 underwent ring closing epoxidation under Mitsunobu conditions23 to 











Figure 2.22 - Initial Transformations for the C21-C30 Fragment Resynthesis 
 
2.9 Publication of the Total Synthesis of N-Acetyl Dihydro-Tetrafibricin Methyl Ester 
In the midst of efforts to scale up the material required to carry out the rest of the synthesis, 
the Roush group published their attempts at the synthesis of tetrafibricin.14 The work performed in 
this document overlapped with previously published work to come out of the Curran group, and 
the strategy did not provide a benefit over the synthesis reported by Roush.  As the result of this, 





Most of the fragments 2–7 have been synthesized in quantities to achieve the synthesis of 
a target amount of 0.5 mmol of tetrafibricin 1 following the successful fragment coupling strategy 
demonstrated by Dr. Zhang.18 Fragment 2 (C35-C40) is available in a 3.9 mmol quantity, and 
fragment 3 (C31-C34) in a 15.0 mmol quantity. Compound 69 (C9-C20), derived from fragments 
5 (C14-C20) and 6 (C9-C13), is available in a 1.3 mmol quantity, with advanced precursors 
totaling over 10 mmol in quantity. Fragment 7 (C1-C8) is available as the more stable allylic 

















Figure 2.23 - Summary of the Fragments of Tetrafibricin 
 
 
The challenges within this synthesis were the result of difficulties stemming from selective 
protecting group manipulation. Finding conditions to differentiate of which silyl groups cleaved 
was difficult and time consuming, and the presence of a large number of silyl groups led to 
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difficulties separating out impurities through physical or chromatographic means to avoid carrying 
them through to late stage intermediates.  
Improvements to the planned synthetic route within this work included reduction the 
number of steps required to synthesize the C1-C8 fragment by indroducing an zinc mediated 
Arbuzov reaction to arrive at the final phosphonate 7. Conversion to the final C14-C20 fragment 
was optimized to increase the yield to 99% on a multi-gram scale. The dithiane-iodide coupling 
reaction between the C9-C13 and C14-C20 fragments was improved to a yield of 98% through 
altering the stoichiometry of the coupling partners. A more mild deprotection strategy was 
deployed on the C9-C20 and C21-C30 fragments in order to selectively cleave a primary silyl-
protected alcohol in the presence of multiple secondary silyl-protected alchohols. This work also 
determined that the tetraenoate moiety of tetrafbricin 1 can tolerate the deprotection conditions 
required to hydrolize a 1,3-dithiane to a ketone using mercury perchlorate trihydrate.  
The work presented in this chapter did not result in publication. The content overlapped 
with previously published work, nor provided an appreciable benefit over the synthesis published 
by the Roush group. However, the studies and improvements made to the synthesis were highly 
beneficial for material throughput to fulfill increased material demands to perform the final 
fragment coupling strategy. 
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3.0 Experimental 
Commercially available chemicals were used as received (Sigma-Aldrich). Solvents were 
dried by passing through an activated alumina column under and atmosphere of argon, unless 
otherwise noted. When noted, dry THF was prepared by distillation from sodium benzophenone 
ketyl under a dry argon atmosphere. Water-sensitive reactions were carried out under an inert 
atmosphere of dry argon. TLC analysis was performed by illumination with a UV lamp (254 nm) 
or by staining with a PMA solution in ethanol and heating. All flash chromatography was 
performed on a CombiFlash instrument (Teledyne Isco), using pre–packed silica gel cartridges. 1H 
NMR spectra were recorded at 293K on a Bruker Avance 300 and 400 instruments using 
deuterated chloroform (CDCl3) as solvent, unless otherwise indicated. 13C NMR spectra were 
measured on Bruker Avance instruments at 75 and100 MHz, unless otherwise indicated. The 
chemical shifts in spectra were measured in parts per million (ppm) on the delta (δ) scale. 1H NMR 
speactra were calibrated relative to the tetramethylsilane (δ 0.00 ppm). 13C NMR spectra were 












1-ol (39): AcOH (0.31 mL, 5.5 mmol) and TBAF (1M in THF, 5.5 mL, 5.5 mmol) was added to a 
solution of 38 (1.02 g, 1.1 mmol) in THF (22 mL). After 7 h, the reaction was quenched with 
saturated NaHCO3, and extracted with Et2O. The combined organic layers were dried over MgSO4, 
and concentrated under reduced pressure. The crude product was purified by flash chromatography 
(SiO2, 10% ethyl acetate in hexanes) to give 39 (159 mg, 18%), recovered 38 (479 mg, 46%), and 
a mixture of desilylated products (179 mg). 1H NMR (400 MHz, CDCl3) δ 7.24 (d, 2H), 6.86 (d, J 
= 8.2 Hz, 2H), 4.44 (s, 2H), 3.90-3.75 (m, 7H), 3.60 (dd, J = 10.7, 4.6 Hz, 1H), 3.52-3.39 (m, 3H), 
1.88 (t, J = 6.1 Hz, 1H), 1.81 (quint, J = 6.2 Hz, 1H), 1.74-1.52 (m, 6H), 0.92-0.82 (m, 36H), 0.11-







Triethylsilyl chloride (0.11 mL, 0.65 mmol) was added to a solution of 39 (193 mg, 0.24 mmol), 
imidazole (64 mg, 0.93 mmol), and DMAP (~2 mg) in DMF (2.5 mL). After 3 h, the reaction was 
quenched with saturated NaHCO3 (3 mL) and extracted with Et2O. The organic layers were 
combined, dried over MgSO4, and concentrated under reduced pressure. The crude product was 
purified by flash chromatography (SiO2, 5% ethyl acetate in hexanes) to give 40 (166 mg, 75%) 
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as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.24 (d, 2H), 6.86 (d, J = 8.3 Hz, 2H), 4.41 (s, 2H), 
3.93-3.74 (m, 7H), 3.54-3.43 (m, 3H), 3.37 (dd, J =10.0, 5.4 Hz, 1H), 1.86-1.40 (m, 8H), 0.95 (t, 






(41): 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (16 mg, 0.070 mmol) was added to a solution 
of PMB ether 40 (50 mg, 0.054 mmol) in dichloromethane (1.8 mL) and pH 7 buffer (0.18 mL). 
After 2.5 h, the reaction was quenched with saturated NaHCO3 (2 mL). The organic layer was 
separated and the aqueous layer was extracted with dichloromethane. The combined organic layers 
were dried over MgSO4, concentrated, and purified via flash chromatography to yield alcohol 41 
(35 mg, 85%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 3.97 (t, J = 5.4 Hz, 1H), 3.93-3.66 (m, 
5H), 3.50 (dd, J = 9.9, 5.6 Hz, 1H), 3.40 (J = 9.9, 5.4 Hz, 1H), 2.39 (t, J = 5.2 Hz, 1H), 1.94-1.59 
(m, 6H), 1.52-1.41 (m, 1H), 0.95 (t, J = 8.0 Hz, 9H), 0.92-0.82 (m, 36H), 0.59 (q, J =7.8 Hz, 6H), 




(S)-2-(4-Methoxybenzyloxymethyl)oxirane (46): A solution of (S)-(–)-glycidol (5.0 g, 67.5 
mmol) in dry THF (10 mL) was slowly added to a suspension of NaH (60%, 4.05 g, 101.2 mmol) 
in THF (40 mL) at 0 ˚C. After 1 h, p-methoxybenzyl chloride (13.8 mL, 101.2 mmol) and n-
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tetrabutylammonium iodide (3.7 g, 10.1 mmol) were added. The reaction was warmed to room 
temperature overnight, then poured in H2O (50 mL). The organic layer was separated, and the 
aqueous layer was extracted with Et2O. The combined organic layers were washed with H2O (50 
mL) then brine (50 mL), dried over MgSO4, then concentrated. The crude product mixture was 
purified by flash chromatography to give 46 (8.4 g, 64%) as a pale yellow oil. 1H NMR (400 MHz, 
CDCl3) δ 7.28 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 4.52 (q, J = 11.6 Hz, 2H), 3.81 (s, 3H), 
3.73 (dd, J = 11.4, 3.1 Hz, 1H), 3.42 (dd, J =11.4, 5.8 Hz, 1H), 3.17 (sext, J = 3.1 Hz, 1H), 2.80 






methoxybenzyloxy)propan-2-ol (47): tert-Butyllithium (1.7 M in pentane, 31 mL, 50 mmol) was 
added to a solution of dithiane 45 (20.2 g, 47.9 mmol) in freshly distilled THF (80 mL) and HMPA 
(20 mL) at –78 ˚C. After 10 min, a solution of epoxide 46 (22.2 g, 114 mmol) in THF (130 mL) 
was added over 1 h. The reaction was warmed to 0 ˚C after 15 min, and allowed to stir at that 
temperature for 1.5 h. The reaction mixture was poured into saturated aqueous NH4Cl solution 
(100 mL) and the aqueous layer was extracted with ethyl acetate. The combined organic layers 
were dried over MgSO4, concentrated, and purified by flash column chromatography (25% ethyl 
acetate in hexanes) to provide 47 (14.6 g, 58%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.26 
(d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 4.49 (s, 2H), 4.33-4.25 (m, 1H), 4.10-4.03 (m, 1H), 
3.81 (s, 3H), 3.59 (dd, J =9.7, 4.7 Hz, 1H), 3.45-3.35 (m, 3H), 3.14 (d, J = 2.7 Hz, 1H), 2.96-2.78 
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(m, 3H), 2.78-2.68 (m, 1H), 2.60 (dd, J = 15.1, 2.8 Hz, 1 H), 2.25 (dd, J = 15.4, 8.3 Hz, 1H), 1.98-






(48): (CAUTION: Mercury (II) perchlorate trihydrate poses a risk of explosion if the reaction is 
not able to dissipate heat efficiently!25 Monitor reaction temperature closely while slowly adding 
the mercury salt to the reaction!) Hg(ClO4)2.•3H2O (7.06 g, 16.9 mmol) was added in portions to 
a solution of 47 (4.16 g, 6.7 mmol) and 2,6-lutidine (3.9 mL, 33.7 mmol) in 4:1 THF/H2O (100 
mL) at 0 ˚C. After 1.5 h, the reaction was filtered through a pad of celite, and rinsed with ethyl 
acetate. The mixture was diluted with ethyl acetate (200 mL), and washed with saturated aqueous 
NH4Cl. The combined organic layers were extracted with ethyl acetate, and the combined organic 
layers were dried over MgSO4, concentrated, and purified by flash chromatography (25% ethyl 
acetate in hexanes) to give ketone 48 (3.10 g, 87%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 
7.25 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 4.45 (s, 2H), 4.28-4.20 (m, 1H), 4.20-4.14 (m, 
1H), 3.81 (s, 3H), 3.56 (dd, J = 9.9, 4.9 Hz, 1H), 3.47-3.34 (m, 3H), 3.01 (d, J = 3.6 Hz), 2.75-2.60 
(m, 3H), 2.55 (dd, J = 15.7, 7.3 Hz, 1 H), 0.87 (s, 9H), 0.84 (s, 9H), 0.06 (s, 3H), 0.05-0.02 (m, 
9H); 13C NMR (75 MHz, CDCl3) δ 209.8, 159.4, 130.2, 129.5, 114.0, 73.2, 73.1, 69.7, 67.1, 66.9, 







(49): Diethylmethoxyborane (1.0 M in THF, 32.9 mL, 32.9 mmol) was added to a solution of 
ketone 48 (15.8 g, 29.9 mmol) in THF (240 mL) and MeOH (60 mL) at –78 ˚C. After 30 minutes, 
sodium borohydride (1.36 g, 35.9 mmol) was added in portions. The reaction was warmed to 0 ˚C 
after 3 h, to which was added 3 N NaOH (46 mL), and 30% H2O2 (19 mL). After 1 h, the reaction 
was quenched with H2O (500 mL) and diluted with diethyl ether (500 mL). The organic layer was 
separated, and the aqueous layer was extracted with diethyl ether. The combined organic layers 
were washed with H2O (500 mL) then brine (500 mL), dried over MgSO4, and concentrated. The 
crude product was purified by flash chromatography (25% ethyl acetate in hexanes) to give 
syn,syn-diol 50 (14.94 g, 94%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.6 Hz, 
2H) 6.87 (d, J = 8.6 Hz, 2H), 4.49 (s, 2H), 4.12-4.00 (m, 2H), 3.94 (s, 1H), 3.93-3.85 (m, 1H), 3.81 
(s, 3H), 3.65 (d, J = 1.5 Hz, 1H), 3.59 (dd, J = 10.1, 4.3 Hz, 1H), 3.47 (dd, J = 10.1, 6.6 Hz, 1H), 
3.44-3.37 (m, 2H), 1.75 (ddd, J =14.3, 5.1, 3.1 Hz, 1H), 1.69-1.56 (m, 3H), 0.89 (s, 9H), 0.88 (s, 
9H), 0.09 (s, 6H), 0.06 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 159.3, 130.3, 129.4, 113.8, 74.1, 










butyldimethylsilyloxy)propyl)-1,3,2-dioxaborinane (50): This compound was isolated from the 
purification of 50, as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H), 6.87 (d, 
J =8.6 Hz, 2H), 4.52 (s, 2H), 4.17-4.04 (m, 2H), 3.91 (quint, J = 5.6 Hz, 1H), 3.81 (s, 3H), 3.61 
(dd, J =10.3, 5.6 Hz, 1H), 3.54-3.48 (m, 2H), 3.39 (dd, J = 9.9 Hz, 5.4 Hz), 1.96 (dt, J = 13.8, 2.7 
Hz, 1H), 1.69 (t, J = 6.2 Hz, 2H), 1.37 (dt, J = 13.7, 11.5 Hz, 1H), 0.90-0.84 (m, 21H), 0.67 (q, J 
= 7.8 Hz, 2H), 0.08-0.02 (m, 12H); 13C NMR (75 MHz, CDCl3) δ 159.3, 130.3, 129.2, 113.8, 73.5, 
73.1, 70.5, 70.3, 68.1, 67.7, 55.1, 42.6, 36.2, 26.0, 26.0, 18.4, 18.1, 7.9, 7.2, –4.2, –4.8, –5.3, –5.3; 
11B NMR (96 MHz, CDCl3) δ +31.0 (br s); LRMS (TOF ES) m/z: Calcd for C29H56BO6Si2 [M+H]+ 






methoxybenzene (51): tert-Butyldimethylsilyl trifluoromethanesulfonate (8.7 mL, 37.8 mmol) 
was added to a solution of diol 50 (9.09 g, 17.2 mmol) and 2,6-lutidine (6.0 mL, 51.6 mmol) in 
dichloromethane (85 mL) at 0 ˚C. The reaction was warmed to room temperature overnight, then 
poured into H2O (85 mL). The organic layer was separated and washed with H2O. The organic 
layer was dried over MgSO4, concentrated, and purified via flash chromatography (10% ethyl 
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acetate in hexanes to yield 51 (12.6 g, 96%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.24 (d, 
J =8.6 Hz, 2H), 6.85 (d, J = 8.3 Hz, 2H), 4.44 (q, J = 10.9 Hz, 2H), 3.98-3.91 (m, 1H), 3.87-3.75 
(m, 5H), 3.51 (dd, J = 9.9, 4.5 Hz, 1H), 3.47-3.36 (m, 2H), 3.30 (dd, J = 9.7, 6.3 Hz, 1H), 1.77-
1.64 (m, 2H), 1.63-1.52 (m, 2H), 0.90-0.84 (m, 36H), 0.06-0.01 (m, 24H); 13C NMR (75 MHz, 
CDCl3) δ 159.2, 130.8, 129.3, 113.8, 74.7, 73.0, 70.8, 69.3, 67.9, 66.9, 55.3, 43.0, 42.8, 26.2, 26.1, 






dicyano-1,4-benzoquinone (2.61 g, 11.5 mmol) was added to a solution of PMB ether 51 (6.69 g, 
8.8 mmol) in dichloromethane (166 mL) and pH 7 buffer (9 mL). After 1 h, the reaction was diluted 
with dichloromethane (100 mL) and quenched with saturated NaHCO3 (100 mL). The organic 
layer was separated and the aqueous layer was extracted with dichloromethane. The combined 
organic layers were dried over MgSO4, concentrated, and purified via flash chromatography to 
yield alcohol 52 (5.50 g, 98%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 3.99-3.89 (m, 2H), 
3.69 (sext, J = 4.7 Hz, 1H), 3.62-3.54 (m, 1H), 3.53-3.37 (m, 3H), 2.71 (dd, J =7.9, 5.4 Hz, 1H), 
1.82-1.74 (m, 2H), 1.73-1.58 (m, 2H), 0.90-0.86 (m, 36H), 0.10-0.03 (m, 24H); 13C NMR (75 
MHz, CDCl3) 70.8, 70.0, 67.9, 67.2, 66.6, 42.4, 41.8, 26.1, 26.0, 26.0, 18.5, 18.2, 18.1, –3.8, –4.2, 







(2S,4R,6R)-1,2,4,6-Tetrakis(tert-butyldimethylsilyloxy)-7-iodoheptane (5): Imidazole (214 
mg, 3.14 mmol), triphenylphosphine (740 mg, 2.82 mmol), and iodine (756 mg, 2.98 mmol) were 
added in that order to a solution of alcohol 52 (1.00 g, 1.57 mmol) in benzene (20 mL). After 1 h, 
the reaction was quenched with saturated Na2S2O3 (20 mL). The organic layer was separated, and 
the aqueous layer was extracted with diethyl ether. The combined organic extracts were dried over 
MgSO4 and concentrated. The crude product was purified by flash chromatography (5% 
dicholomethane in hexanes) to yield iodide 5 (1.16g, 99%) as a clear oil. 1H NMR (400 MHz, 
CDCl3) δ 3.81 (ddd, J = 10.4, 7.4, 5.4 Hz, 1H), 3.85-3.70 (m, 2H), 3.68-3.61 (m, 1H), 3.51-3.43 
(m, 2H), 3.34 (dd, J = 10.2, 4.1 Hz, 1H), 3.20 (dd, J = 10.2, 4.8 Hz, 1H), 1.83-1.56 (m, 4H), 0.91-
0.87 (m, 36H), 0.11 (s, 3H), 0.09-0.03 (m, 21H); 13C NMR (75 MHz, CDCl3) δ 70.8, 68.4, 67.7, 






Butyldiethylphosphonoacetate (0.20 mL, 0.87 mmol) was slowly added to a suspension of NaH 
(35 mg, 0.87 mmol) in THF (8 mL) at 0 ˚C. After 20 min, the reaction was cooled to –78 ˚C. The 
reaction mixture was added via cannula to a solution of aldehyde 63 (178 mg, 0.79 mmol) in THF 
(8 mL) at –78 ˚C. The reaction was allowed to warm to room temperature and after 2 h was 
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quenched with saturated aqueous NaHCO3  solution (8 mL). The organic layer was separated, and 
the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with 
saturated aqueous NaCl solution, dried over MgSO4 and concentrated. The crude product was 
purified by flash column chromatography (SiO2, 5% ethyl acetate in hexanes) to yield ester 64 
(197 mg, 77%) as a clear oil. 1H NMR (300 MHz, CDCl3) δ 7.20 (dd, J = 15.2, 11.2 Hz, 1H), 6.54 
(dd, J = 14.8, 10.8 Hz, 1H), 6.37-6.23 (m, 2H), 5.96 (dt, J = 15.2, 5.2 Hz, 1 H), 5.80 (d, J = 15.2, 
1H), 4.27 (d, J = 4.4 Hz, 2H), 1.49 (s, 9H), 0.92 (s, 9H), 0.08 (s, 6H); 13C NMR (75 MHz, CDCl3) 
δ 166.6, 143.5, 139.6, 138.6, 137.3, 133.5, 129.5, 128.8, 124.9, 122.9, 80.2, 63.3, 29.8, 28.3, 26.0, 
18.5, –5.2; HRMS (TOF ES) m/z: Calcd for C18H33O3Si [M+H]+ 325.2193; Found 325.2155; IR 




(2E,4E,6E)-tert-Butyl 8-hydroxyocta-2,4,6-trienoate (65): A solution of tetrabutylammonium 
fluoride (1.0M in THF 1.31 mL) was added directly to silyl ether 64 (404 mg, 1.24 mmol). After 
30 min, the mixture was diluted with ethyl acetate 85 mL) and washed with water. The organic 
layer was dried over MgSO4 and concentrated. The crude mixture was purified by flash 
chromatography (SiO2, 5-50% ethyl acetate in hexanes) to yield alcohol 65 (250 mg, 96%) as a 
white solid. 1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 15.2, 12.0 Hz, 1H), 6.54 (dd,  J = 15.2, 
10.8 Hz, 1H), 6.33 (m, 2H), 6.02 (dt, J = 15.2, 5.2 Hz, 1H), 5.82 (d, J =15.6 Hz, 1H), 4.26 (t, J  = 
4.8 Hz, 2H), 1.49 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 166.6, 143.5, 139.5, 137.1, 129.8, 129.6, 







(2E,4E,6E)-tert-Butyl 8-bromoocta-2,4,6-trienoate (66): 2,6-lutidine (0.33 mL, 2.85 mmol), 
then thionyl bromide (0.18 mL, 2.38 mmol) was added to a solution of alcohol 65 (200 mg, 0.95 
mmol) in THF (3.5 mL) at -20 ˚C and stirred for 1.5 h. The reaction was allowed to slowly warm 
to room temperature over 1.5 h, then was quenched with saturated NaHCO3 solution (8 mL). The 
organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined 
organic layers were dried over MgSO4 and concentrated. The crude product was purified by flash 
chromatography (SiO2, 10% ethyl acetate in hexanes) to give bromide 66 (119 mg, 46%) as a pale 
yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.18 (dd, J = 15.3, 11.1 Hz, 1H), 6.50 (dd, J = 14.7, 10.8 
Hz, 1H), 6.39-6.28 (m, 2H), 6.03 (dt, J = 15.0, 7.8 Hz, 1H), 5.84 (d, J = 15.3 Hz, 1 H), 4.04 (d, J 
= 7.8 Hz, 2H), 1.49s (s, 9H); 13C NMR (75 MHz, CDCl3) δ 166.2, 142.6, 137.9, 134.0, 132.4, 





(2E,4E,6E)-tert-Butyl 8-(diethoxyphosphoryl)octa-2,4,6-trienoate (7): Procedure A: Bromide 
66 (118 mg, 0.43 mmol) was added to a sealed flask and dissolved in toluene (1.6 mL). Triethyl 
phosphite (1.6 mL) was added, the flask was sealed, and the reaction was heated to 110 ˚C for 9 
h. The reaction was cooled to room temperature, concentrated under reduced pressure, and the 
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crude product was purified by flash chromatography (SiO2, 50% ethyl acetate in hexanes) to give 
phosphonate 7 (75 mg, 56%) as a white, waxy solid. Procedure B: Triethylphosphite (0.49 mL, 
2.85 mmol), zinc iodide (455mg, 1.43 mmol), and allylic alcohol 65 (100mg, 0.48 mmol) were 
added to a sealed flask in that order, and heated at 55 ˚C for 2.5 h. The mixture was cooled to room 
temperature and added to 2 M NaOH (200 mL), then extracted with diethyl ether. The combined 
organic layers were dried over MgSO4 and concentrated. Then crude product mixture was purified 
by flash column chromatography (25 to 100% ethyl acetate in hexanes) to give phosphonate 7 (86 
mg, 54%) as white waxy solid. 1H NMR (400 MHz, CDCl3) δ 7.17 (dd, J = 15.2, 11.2 Hz, 1H), 
6.51 (dd, J = 14.8, 10.8 Hz, 1H), 6.30-6.22 (m, 2H), 5.88-5.79 (m, 2H), 4.11 (dquint, J = 7.2, 2.0 
Hz, 4H), 2.69 (dd, J = 23.2, 8.0 Hz, 2H), 1.49 (s, 9H), 1.32 (t, J = 6.8 Hz, 6H); 13C NMR (75 MHz, 
CDCl3) δ 166.4, 143.2, 139.0 (JC–P = 5 Hz), 134.4 (JC–P = 15 Hz), 129.8 (JC–P = 5 Hz), 80.3, 62.1 
(JC–P = 7 Hz), 31.2 (JC–P = 139 Hz), 28.2, 16.5 (JC–P = 6 Hz). HRMS (TOF ES) m/z: Calcd for 
C16H28O5P [M+H]+ 331.1669; Found 331.1696; IR (neat) cm-1 2979, 2931, 1702, 1618, 1243, 
1132, 1025, 964, 846. The spectroscopic data is in agreement with the previously reported ethyl 






butyldimethylsilyloxy)pent-4-en-2-yl)-1,3-dithiane (13): tert-Butyllithium (1.7 M in pentane, 
0.20 mL, 0.3 mmol) was added to a solution of dithiane 6 (1.00 g, 3.14 mmol) and HMPA (2.1 
mL) in freshly distilled THF (15 mL) at –78 ˚C until a yellow color persisted, after which the 
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remainder (2.0 mL, 3.4 mmol) was added. After 1 h, a solution of iodide 5 (2.10 g, 2.81 mmol) in 
THF (4 mL) was added dropwise. After 2 h, the reaction was quenched with saturated NH4Cl (15 
mL). The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The 
combined organic extracts were washed with H2O, then brine, dried over MgSO4, concentrated, 
and purified by flash chromatography (10% dichloromethane in hexanes) to yield 13 (2.53 g, 96%) 
as a white waxy solid. 1H NMR (400 MHz, CDCl3) δ 5.94 (ddd, J = 17.3, 10.1, 7.4 Hz, 1H), 5.12 
(d, J = 17.1 Hz, 1H), 5.01 (d, J = 10.6 Hz, 1H), 4.93 (d, J = 7.7 Hz, 1H), 4.21 (quin, J = 5.2 Hz, 
1H), 3.88-3.84 (m, 1H), 3.78-3.75 (m, 1H), 3.61 (dd, J = 10.1, 3.6 Hz, 1H), 3.43 (dd, J = 10.0, 7.2 
Hz, 1H), 2.88-2.76 (m, 2H), 2.59-2.48 (m, 2H), 2.27 (q, J = 7.0 Hz, 1H), 1.98-1.87 (m, 3H), 1.85-
1.58 (m, 5H), 1.09 (d, J = 7.0 Hz, 3H), 0.91-0.85 (m, 45H), 0.20 (s, 3H), 0.13 (s, 3H), 0.10-0.02 
(m, 24H); 13C NMR (100 MHz, CDCl3) δ 143.5, 113.7, 71.2, 67.8, 67.5, 67.0, 58.2, 49.5, 44.4, 







yl)-3-(tert-butyldimethylsilyloxy)pentan-1-ol (67): 9-BBN (0.5 M in THF, 42.7 mL, 21.3 mmol) 
was added directly to alkene 13 (5.0 g, 5.3 mmol). After 12 h the reaction was cooled to 0 ˚C, then 
H2O (45 mL) and NaBO3•4H2O (9.84 g, 64.0 mmol) was added. After 5 h, the reaction was diluted 
with H2O (45 mL) and diethyl ether (90 mL). The organic layer was separated and the aqueous 
layer was extracted with diethyl ether. The combined organic extracts were dried over MgSO4, 
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concentrated, and purified by flash chromatography (15% ethyl acetate in hexanes) to give alcohol 
67 (4.35 g, 85%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 4.46 (dd, J = 9.1, 3.2 Hz, 1H), 4.22-
4.13 (m, 1H), 3.92-3.82 (m, 1H), 3.82-3.67 (m, 3H), 3.61 (dd, J = 10.1, 3.3 Hz, 1H), 3.42 (dd, J = 
10.0, 7.3 Hz, 1H), 2.88 (ddd, J = 13.7, 11.5, 2.3 Hz, 1H), 2.78 (ddd, J = 13.4, 10.8, 2.5 Hz, 1H), 
2.67-2.54 (m, 2H), 2.45-2.37 (m, 1H), 2.02-1.60 (m, 12H), 1.05 (d, J = 6.9 Hz, 3H), 0.96-0.79 (m, 
45H), 0.18 (s, 3H), 0.13-0.02 (m, 27H); 13C NMR (100 MHz, CDCl3) δ 71.2, 69.3, 68.1, 67.8, 
67.5, 67.1, 60.0, 58.1, 49.5, 44.5, 42.6, 42.1, 41.4, 40.7, 27.3, 26.3, 26.2, 26.1, 26.0, 25.8, 25.8, 






yl)-3-(tert-butyldimethylsilyloxy)pentyl benzoate (68): Benzoyl chloride (0.13 mL, 1.04 mmol) 
was added to a solution of alcohol 67 (0.90 g, 0.94 mmol), triethylamine (0.20 mL, 1.41 mmol), 
and DMAP (12 mg, 0.094 mmol) in dichloromethane (10 mL). After 4h, the reaction was quenched 
with saturated NaHCO3 (10 mL). The organic layer was separated and the aqueous layer was 
extracted with dichloromethane. The combined organic extracts were dried over MgSO4, 
concentrated, and purified by flash chromatography (10% ethyl acetate in hexanes) to yield 
benzoyl ester 68 (0.94 g, 94%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 7.3 Hz, 
2H), 7.56 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.6 Hz, 2H), 4.64 (dd, J = 9.0, 3.4 Hz, 1H), 4.45-4.27 (m, 
2H), 4.22-4.14 (m, 1H), 3.93-3.83 (m, 1H), 3.82-3.71 (m, 1H), 3.62 (dd, J = 10.0, 3.4 Hz, 1H), 
3.41 (dd, J = 10.0, 7.4 Hz, 1H), 2.85-2.70 (m, 2H), 2.54-2.39 (m, 3H), 2.12-1.57 (m, 10H), 1.09 
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(d, J = 7.2 Hz, 3H), 0.92-0.82 (m, 45H), 0.19-0.01 (m, 30H); 13C NMR (100 MHz, CDCl3) δ 166.7, 
133.1, 130.3, 129.7, 128.5, 71.3, 68.9, 67.8, 67.5, 67.1, 62.1, 57.9, 49.7, 44.6, 42.7, 41.2, 37.2, 
26.3, 26.2, 26.2, 24.5, 18.5, 18.4, 18.4, 18.2, 18.2, 9.9, –3.0, –3.0, –3.7, –3.8, –3.9, –3.9, –4.2, –






dithian-2-yl)-3-(tert-butyldimethylsilyloxy)pentyl benzoate (69): AcOH (0.24 mL, 4.6 mmol) 
and TBAF (1M in THF, 4.6 mL, 4.6 mmol) were added to a solution of 68 (487 mg, 0.46 mmol) 
in THF (4.6 mL) at 0 ˚C. The reaction was warmed to room temperature, and was quenched after 
6 h with 8 mL saturated NaHCO3 (8 mL), and diluted with diethyl ether (8 mL). The organic layer 
was separated, and the aqueous layer was extracted with diethyl ether. The combined organic 
layers were dried over MgSO4, concentrated, and purified by flash chromatography (10% ethyl 
acetate in hexanes) to give primary alcohol 69 (114 mg, 26%) as well as recovered 68 (280 mg, 
57%), and a mixture of desilylated products 70 (73 mg). Recovered 68 was resubjected to these 
conditions to provide additional 69. 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 7.4 Hz, 2H), 7.57 
(t, 7.3 Hz, 1H), 7.44 (t, J = 7.7 Hz, 2H), 4.57 (dd, J = 9.3, 3.1 Hz, 1H), 4.43-4.28 (m, 2H), 4.18-
4.04 (m, 2H), 3.96-3.86 (m, 2H), 3.62-3.53 (m, 1H), 3.52-3.43 (m, 1H), 2.92-2.70 (m, 1H), 2.54-
2.40 (m, 1H), 2.15-1.65 (m, 10H), 1.08 (d, J = 6.9 Hz, 3H), 0.92-0.85 (m, 36H), 0.20-0.01 (m, 
24H); 13C NMR (100 MHz, CDCl3) δ 166.7, 133.1, 130.3, 129.7, 128.5, 70.4, 68.8, 67.7, 67.0, 
66.6, 62.0, 57.6, 49.3, 45.3, 41.4, 41.1, 37.1, 26.4, 26.3, 26.2, 26.0, 25.7, 24.2, 18.4, 18.2, 18.2, 
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(3S, 4S)-3-tert-Butyldimethylsilyloxy-4-(1,3-dithian-2-yl)-1-pentene (anti-6): tert-
Butyldimethylsilyl trifluoromethanesulfonate (2.9 mL, 12.7 mmol) was added to a solution of 
(S,S)-58 (2.35 g, 11.5 mmol) and 2,6-lutidine (1.6 mL, 13.8 mmol) in dichloromethane (115 mL) 
at –78 ˚C. After 15 min, the reaction was warmed to 0 ˚C. After 2 h, the reaction was allowed to 
warm to room temperature overnight. The reaction was quenched with H2O (50 mL). The organic 
layer was separated, and the aqueous layer was extracted with dichloromethane. The combined 
organic layers were dried over MgSO4, concentrated, and purified via flash chromatography (10% 
ethyl acetate in hexanes to give anti-6 (3.60 g, 98%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 
5.68 (ddd, J = 17.3, 10.2, 7.5 Hz, 1H), 5.20-5.11 (m, 2H), 4.47 (d, J = 4.3 Hz, 1H), 4.13 (t, J = 8.0 
Hz, 1H), 3.01-2.76 (m, 4H), 2.15-2.06 (m, 1H), 1.94-1.79 (m, 2H), 0.96 (d, J = 7.0 Hz, 3H), 0.91 






(71): tert-Butyllithium (1.7 M in pentane, 7.0 mL, 11.9 mmol) was added slowly to a solution of 
dithiane anti-6 (3.44 g, 10.8 mmol)  and HMPA (4.3 mL) dissolved in freshly distilled THF (17 
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mL) at –78 ˚C. After 10 min, a solution of 1,2-epoxydodecane (2.6 mL, 11.9 mmol) in THF (5 
mL) was added to the reaction. After 15 min, the reaction was warmed to 0 ˚C. After 1 h, the 
reaction was quenched with saturated NH4Cl (20 mL). The organic layer was separated, and the 
aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4, concentrated, and purified by flash chromatography (SiO2, 5% ethyl acetate in hexanes) 
to give 71 (3.95 g, 72%) as a 55:45 mixture of two diastereomers. 1H NMR (400 MHz, CDCl3) 
Major diastereomer: δ 5.94 (ddd, J =17.1, 10.5, 6.5 Hz, 1H), 5.19-5.10 (m, 2H), 4.68-4.61 (m, 
1H), 4.12-4.03 (m, 1H), 3.45 (d, J = 1.6 Hz, 1H), 1.18 (d, J = 7.0 Hz, 3H); Minor diastereomer: 
δ 6.09 (ddd, J = 16.4, 11.0, 6.0 Hz, 1H), 5.30-5.19 (m, 2H), 4.93-4.87 (m, 1H), 4.03-3.96 (m, 1H), 
3.65 (d, J = 1.2 Hz, 1H), 1.00 (d, J = 7.1Hz, 3H); Shared peaks: δ 2.98-2.74 (m, 8H), 2.54-2.37 
(m, 2H), 2.32-2.21 (m, 1H), 2.11-1.88 (m, 8H), 1.34-1.23 (m, 36H), 0.92-0.85 (m, 24H), 0.11 (s, 
3H), 0.08 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 139.0, 138.4, 116.5, 
115.9, 73.3, 73.3, 68.5, 68.4, 55.9, 55.7, 46.7, 46.1, 42.9, 42.8, 38.1, 32.0, 29.8, 29.8, 29.7, 29.5, 
26.5, 26.4, 26.1, 26.0, 26.0, 25.9, 25.7, 25.7, 25.0, 24.7, 22.8, 18.3, 18.2, 18.2, 14.3, 9.5, 9.4, –4.1, 






butyldimethylsilyloxy)dodecyl-1,3-dithiane (72):  tert-Butyldimethylsilyl 
trifluoromethanesulfonate (1.52 mL, 8.64 mmol) was added to a solution of alcohol 71 (3.95 g, 
7.85 mmol) and 2,6-lutidine (1.10 mL, 9.43 mmol) in dichloromethane (78 mL) at –78 ˚C. After 
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15 min, the reaction was warmed to 0 ˚C. After 2 h, the reaction was allowed to warm to room 
temperature overnight. The reaction was quenched with H2O (40 mL). The organic layer was 
separated, and the aqueous layer was extracted with dichloromethane. The combined organic 
layers were dried over MgSO4, concentrated, and purified via flash chromatography (10% ethyl 
acetate in hexanes to give 72 (3.62 g, 75%) as a 53:47 mixture of two diastereomers. 1H NMR 
(400 MHz, CDCl3) Major diastereomer: δ 5.14-5.09 (m, 2H), 4.07-4.03 (m, 2H), 2.78-2.65 (m, 
4H), 1.06 (d, J = 7.3 Hz, 3H); Minor diastereomer: δ 5.27-5.29 (m, 2H), 4.91-4.84 (m, 2H), 2.92-
2.78 (m, 4H), 1.02 (d, J = 7.0 Hz, 3H); Shared peaks: δ 6.08-5.95 (m, 2H), 2.55-2.42 (m, 2H), 
2.14-2.03 (m, 2H), 2.02-1.58 (m, 10H), 1.51-1.36 (m, 2H), 1.35-1.20 (m, 38H), 0.92-0.85 (m, 






dithian-2-yl)pentan-1-ol (73): A solution of 9-BBN (0.5 M in THF, 25.3 mL, 12.64 mmol) was 
added to a solution of alkene 72 (2.60 g, 4.21 mmol) in THF (42 mL). After 15 h, the reaction was 
cooled to 0 ˚C. H2O2 (30% in H2O, 21 mL), then 3N NaOH (26 mL) were added to the reaction 
and allowed to warm to room temperature. After 7 h, the reaction was diluted with ethyl acetate 
(210 mL) and H2O (105 mL). The organic layer was separate, and the aqueous layer was extracted 
with ethyl acetate. The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. The crude product was purified by flash chromatography (SiO2, 10% ethyl 
acetate in hexanes) to give alcohol 73 (1.64g, 61%) as a 1:1 mixture of two diastereomers. 1H 
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NMR (400 MHz, CDCl3) δ 4.53 (t, J = 9.8 Hz, 2H), 4.07-3.98 (m, 2H), 3.83-3.66 (m, 4H), 3.02-
2.79 (m, 4H), 2.78-2.67 (m, 3H), 2.66-2.50 (m, 2H), 2.44-2.38 (m, 2H), 2.37-2.21 (m, 4H), 2.20-
2.05 (m, 4H), 2.04-1.93 (m, 4H), 1.93-1.83 (m, 4H), 1.45-1.34 (m, 6H), 1.33-1.19 (m, 36H), 1.15 
(d, J = 7.0 Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H), 0.92-0.85 (m, 42H), 0.16-0.12 (m, 12H), 0.10-0.07 
(m, 12H); 13C NMR (100 MHz, CDCl3) δ 76.8, 71.7, 71.3, 70.4, 70.0, 61.4, 61.2, 55.8, 55.8, 45.9, 
45.4, 44.1, 43.9, 42.0, 39.3, 39.0, 36.2, 35.5, 32.0, 30.0, 29.9, 29.8, 29.8, 29,7, 29.4, 27.3, 27.0, 
26.6, 26.5, 26.2, 26.2, 26.0, 26.0, 25.8, 25.4, 25.3, 24.8, 24.6, 24.2, 2.8, 18.3, 18.1, 18.1, 14.3, 8.7, 






dithian-2-yl)pentanal (74): NaHCO3 (100 mg, 1.19 mmol) and Dess-Martin periodinane (100 
mg, 0.23 mmol) was added to a solution of alcohol 73 (136 mg, 0.214 mmol) in dichloromethane 
(4.5 mL). After 8 h, the reaction was quenched with saturated NaHCO3 (10 mL). The organic layer 
was separated, and the aqueous layer was extracted with dichloromethane. The combined organic 
layers were dried over MgSO4, then concentrated. The crude product was purified by flash 
chromatography (SiO2, 10% ethyl acetate in hexanes) to give aldehyde 74 (98 mg, 70%) as a 
mixture of two diastereomers. 1H NMR (400 MHz, CDCl3) δ 9.83-9.76 (m, 2H), 5.02 (d, J = 9.2 
Hz, 2H), 4.07-3.93 (m, 2H), 3.16-3.07 (m, 1H), 3.03-2.79 (m, 5H), 2.78-2.65 (m, 3H), 2.65-2.47 
(m, 3H), 2.40-2.15 (m, 4H), 2.15-1.93 (m, 4H), 1.92-1.78 (m, 2H), 1.77-1.62 (m, 2H), 1.47-1.19 
(m, 36H), 1.15 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 7.1 Hz, 3H), 0.93-0.77 (m, 42H), 0.16-0.03 (m, 
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24H); 13C NMR (100 MHz, CDCl3) δ 202.3, 202.1,  70.22, 69.9, 68.3, 68.2, 55.8, 55.5, 49.0, 48.2, 
46.0, 45.3, 44.0, 43.6, 39.3, 39.0, 32.0, 30.0, 30.0, 29.8, 29.7, 29.7, 29.4, 26.9, 26.4, 26.3, 26.3, 
26.2, 26.2, 25.9, 25.8, 25.3, 25.1, 24.5, 24.2, 22.8, 18.2, 18.2, 18.0, 18.0, 14.2, 9.0, 8.0, –3.8, –3.8, 






butyldimethylsilyloxy)dodecyl)-1,3-dithian-2-yl)trideca-2,4,6,8-tetraenoate (75): A solution 
of LiHMDS (1.0M in toluene, 0.16 mL, 0.16 mmol) was added to a solution of phosphonate 7 (56 
mg, 0.17 mmol) in THF (0.85 mL) at –78 ˚C. After 15 min, a solution of aldehyde 74 (68 mg, 0.11 
mmol) in THF (0.70 mL) was slowly added. After 30 min, the reaction was warmed to 0 ˚C. After 
1 h, the reaction was quenched with saturated NH4Cl (2 mL). The organic layer was separated, and 
the aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (SiO2, 10% ethyl acetate in hexanes) to give 75 (78 mg, 90%) as a mixture of two 
diastereomers. 1H NMR (400 MHz, CDCl3) δ 7.22 (dd, J = 15.2, 11.4 Hz, 2H), 6.51 (dd, J = 14.5, 
11.0 Hz, 2H), 6.40-6.07 (m, 8H), 5.92-5.82 (m, 2H), 5.78 (d, J = 15.2 Hz, 2H), 4.34 (dd, 9.2, 3.1 
Hz, 2H), 4.03 (dd, J = 15.0, 4.6 Hz, 2H), 3.01-2.57 (m, 10H), 2.35-2.13 (m, 6H), 2.12-1.83 (m, 
6H), 1.78-1.57 (m, 2H), 1.49 (s, 18H), 1.35-1.22 (m, 36H), 1.14 (d, J = 7.1 Hz, 3H), 1.06 (d, J = 
7.1 Hz, 3H), 0.92-0.84 (m, 42H), 0.11-0.02 (m, 24H); HRMS (TOF ES) m/z: Calcd for 






oxopentacosa-2,4,6,8-tetraenoate (76): Hg(ClO4)2•H2O (59 mg, 0.14 mmol) was added to a 
solution of dithiane 75 (22 mg, 0.028 mmol) and 2,6-lutidine (44 μL, 0.38 mmol) in THF (0.48 
mL) and H2O (0.12 mL) at 0 ˚C. After 45 min, the reaction mixture was filtered through a pad of 
celite and rinsed through with ethyl acetate. The filtrate was diluted with ethyl acetate to a volume 
of 30 mL, and poured into saturated NH4Cl (30 mL). The organic layer was separated, and the 
aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (SiO2, 10% ethyl acetate in hexanes) to give ketone 76 (9.4 mg, 46%) as a mixture 
of two diastereomers. 1H NMR (600 MHz, CDCl3) δ 7.22 (dd, J = 15.2, 11.4 Hz, 2H), 6.54 (dd, J 
= 14.8, 11.1 Hz, 2H), 6.36, (dd, J = 14.4, 12.1 Hz, 2H), 6.28 (d, J = 14.7, 11.4 Hz, 2H), 6.20 (t, J 
= 12.9 Hz, 2H), 6.13 (dd, J = 15.1, 10.7 Hz, 2H), 5.88-5.81 (m, 2H), 5.79 (d, J = 15.4 Hz, 2H), 
4.19-4.09 (m, 2H), 4.02-3.94 (m, 2H), 2.74-2.60 (m, 5H), 2.56 (dd, J = 16.5, 5.3 Hz, 1H), 2.44 
(dd, J = 16.7, 4.6 Hz, 1H), 2.33-2.20 (m, 4H), 1.49 (s, 18H), 1.30-1.21 (s, 18H), 0.98 (d, J = 7.0 
Hz, 3H), 0.95 (d, J = 6.9 Hz, 3H), 0.90-0.82 (m, 42H), 0.09-0.02 (m, 24H); 13C NMR (150 MHz, 
CDCl3) δ 212.3, 211.9, 166.7, 166.3, 143.6, 140.3, 136.9, 133.1, 133.0, 131.1, 130.5, 129.8, 129.8, 
122.6, 80.3, 73.3, 73.2, 68.6, 68.1, 52.1, 52.1, 51.6, 51.0, 38.0, 37.6, 37.5, 32.1, 29.9, 29.8, 29.7, 




Appendix A NMR Spectra of Selected Compounds 
NMR spectra of compounds 5, 6, 7, 13, 39, 40, 41, 46, 47, 48, 49, 50, 51, 52, 64, 65, 66, 
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